Skip to main content

Table 1 Distribution of SDRMs in 23 patients with primary HIVDR*

From: Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand

SDRMs

Number of patients

Prevalence (%)

NRTI-SDRMs

9

1.9

M41L

3

0.6

K65R

1

0.2

D67N

1

0.2

T69D

1

0.2

V75M

1

0.2

M184V

3

0.6

M184I

1

0.2

L210W

1

0.2

T215Y

1

0.2

T215S

1

0.2

K219Q

1

0.2

K219R

1

0.2

NNRTI-SDRMs

13

2.8

K101E

1

0.2

K103N

3

0.6

K103S

1

0.2

V106A

1

0.2

V106M

1

0.2

Y181C

4

0.9

Y181I

1

0.2

Y188L

1

0.2

G190S

1

0.2

PI-SDRMs

8

1.7

M46I

1

0.2

M46L

1

0.2

I47V

1

0.2

G48M

1

0.2

I54L

1

0.2

I54T

1

0.2

I84A

1

0.2

L90M

6

1.3

  1. *some patients had more than one SDRM